Ventripoint Diagnostics Ltd. ('Ventripoint' or the 'Corporation') announced Mr. Hugh MacNaught has been appointed as a Director of the Corporation. Mr. MacNaught is a seasoned life science executive with more than thirty years of experience in the development, commercialization and financing of therapeutic, diagnostic and medical device technologies and ventures. He brings strong business acumen, governance experience and an extensive network of world-class industry experts to drive transformation of technology-based ventures.